Kraig Pepper, DO
Sports Medicine · Fort Worth, TXNPI 1568444107
Payments from drug & device makers
Across 102 payments — averaging $233.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$17K
- Conformis, Inc.$1K
- Zimmer Biomet$1K
- Pylant Medical$937
- Acumed LLC$874
- Arthrex$542
- plus $1K from 22 others
Across 1 payment — averaging $19,688 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$20K
What the payments were for
- Royalty or licence$3501%
- Speaking & faculty fees$15,03063%
- Travel & lodging$3,98217%
- Food & beverage$2,78312%
- Education$1,6277%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 27 | $17,465 |
| Conformis, Inc. | 12 | $1,419 |
| Zimmer Biomet | 4 | $1,107 |
| Pylant Medical | 5 | $937 |
| Acumed LLC | 5 | $874 |
| Arthrex | 3 | $542 |
| Medical Device Business Services, Inc. | 1 | $350 |
| Johnson & Johnson(2 entities) | 6 | $150 |
| Ferring Pharmaceuticals Inc. | 7 | $141 |
| Vericel Corporation | 2 | $141 |
| Bioventus LLC | 4 | $92 |
| Pacira Pharmaceuticals Incorporated | 4 | $81 |
| Orthofix Medical, Inc. | 4 | $61 |
| Medacta USA, Inc. | 1 | $51 |
| Electronic Waveform Lab, Inc. | 3 | $51 |
| Heron Therapeutics, Inc. | 2 | $43 |
| Tenex Health Inc. | 1 | $40 |
| Anika Therapeutics, Inc. | 1 | $31 |
| Globus Medical | 1 | $28 |
| Stryker | 1 | $25 |
| Fidia Pharma USA Inc. | 1 | $24 |
| Davol Inc. | 1 | $23 |
| Acera Surgical, Inc. | 1 | $20 |
| Medtronic | 1 | $17 |
| Si-bone, Inc. | 1 | $16 |
| Dynasplint Systems Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Heraeus Medical, LLC. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JOURNAVX$17,098
- ACUMED$2,085
- Hip$1,146
- iTotal Identity PS$997
- G7$632
- QUICKANCHOR ORTHOCORD$350
- Taperloc$211
- Identity Imprint CR$150
- Identity Imprint PS$150
- GPS III PLATELET CONCENTRATION SYSTEM$146
- MACI$125
- Surgical Product Portfolio$117
How this compares
$23,772 in reported general payments places this provider in the 80th percentile of 437 sports medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 86 | $26,307 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 239 | $2,925 |
| Tizanidine Hcl | 185 | $2,055 |
| Ondansetron Hcl | 220 | $1,703 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 134 | $1,555 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 46 | $296 |
| Tramadol Hcl | 55 | $230 |
| Ibuprofen | 19 | $149 |
| Methylprednisolone | 18 | $106 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $94 |
| Levofloxacin | 11 | $63 |
| Gabapentin | 19 | $55 |
| Amoxicillin | 29 | $33 |
| Meloxicam | 13 | $8 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $150 | $26,30786 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 437 sports medicine providers in Texas.
Other sports medicine in Fort Worth
- Dean PapaliodisFort Worth$37K
- Timothy VachrisAustin$5.7M
- Thomas DeberardinoSan Antonio$3.5M
- Mark HutchensAustin$2.5M
- Robert ScheinbergDallas$2.2M
- Marc LabbeThe Woodlands$2M
- Walter LoweHouston$1.4M
- Reed BartzSunnyvale$1.2M
- David BrownHouston$920K
- James GregoryHouston$848K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.